New study aims to unlock BK virus mysteries in kidney transplants
NCT ID NCT06538961
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This registry study is collecting blood and urine samples from 60 kidney transplant recipients who have BK virus infection. Researchers want to understand how the immune system responds to the virus and how immunosuppressive drugs affect that response. The goal is to find better ways to monitor and treat BK virus, which can cause kidney damage or graft loss.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors better predict and manage BK virus infections after kidney transplant, potentially reducing graft loss.
- What could go wrong
- This is an observational registry, not a treatment trial. It will not directly test any new therapy, and results may take years to influence clinical practice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BK VIRUS INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Virginia Commonwealth University
RECRUITINGRichmond, Virginia, 23298, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can cord blood t cells be trained to stop viral infections after transplant?
- Can a vaccine shield transplant patients from shingles?
- Can a single drug dose forecast transplant kidney health?
- Can specially grown immune cells from donors beat viruses that won't go away?
- Pre-Surgery bootcamp may boost kidney transplant recovery
- Can 'Supercharged' donor cells beat viruses that drugs Can't?